RecallDepth
Class II Terminated

Arformoterol Tartrate Inhalation Solution, 15 mcg/2mL, 2 mL Sterile Unit-Dose Vial packaged in 5 x 2 mL Sterile Unit-Dose Vials per pouch, NDC 69097-168-48; 60 (12 x 5) x 2 mL Sterile Unit-Dose Vials per carton, NDC 69097-168-64, Rx Only, Manufactured by: Cipla Ltd., Indore SEZ, Pithampur, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059.

This recall has been terminated (originally issued October 12, 2022).

Company
Cipla
Recall Initiated
September 29, 2022
Posted
October 12, 2022
Recall Number
D-1550-2022
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
9041 cartons
Firm Location
Warren, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Lack of Assurance of Sterility: environmental monitoring failure.

Distribution

Product was distributed nationwide to distributors/wholesalers who may have further distributed the product.

Lot / Code Info

Batch No: IA10082, IA10083, IA10084, IA10085, IA10086, exp. date 01/2023; IA10122, IA10123, IA10124, IA10125, IA10126, IA10127, IA10128, IA10129, IA10130, exp. date 02/2023

More recalls by Cipla

View all recalls by this company →

Other recent Class II Drug recalls